Endocrine Therapy

Perceived Barriers Associated With Adherence to Aromatase Inhibitors

Perceived Barriers Associated With Adherence to Aromatase Inhibitors

By

Greater negative beliefs regarding the challenges of their aromatase inhibitor treatment more likely to lead to nonadherence.

Oncology Nurses Should Be Aware of Complexities of Neuroendocrine Tumors

Oncology Nurses Should Be Aware of Complexities of Neuroendocrine Tumors

By

Oncology nurses can play a pivotal role in diagnosis and management of the rare neuroendocrine tumors pheochromocytomas and paragangliomas.

AI-only Users vs Tamoxifen Users Have Similar CVD Risk

By

The risk of the most serious cardiovascular events, including cardiac ischemia and stroke, was not higher for breast cancer survivors who received an aromatase inhibitor (AI) compared with tamoxifen users.

Symptom Burden Is Higher for Patients With Breast Cancer Receiving Endocrine Therapy

By

The impact on quality of life for patients with breast cancer receiving adjuvant endocrine therapy (ET) should be given more attention, and clinicians should make better efforts to address patient-reported outcomes.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs